Drug Patent Expirations for Nov 19 2012

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations


ADVERTISE
HERE

This
newsletter is a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents


Simple flat-rate database subscription
plans

Ultimate Plan Premium
Plan
Basic Plan
One year $1,995 Subscribe $1,795 Subscribe $1,095 Subscribe
One month $525 Subscribe $425 Subscribe $325 Subscribe
48 hours $95 Subscribe $75 Subscribe
Free
Trial
    Plan
comparison
    Site
tour
    Discount
schedule
    Contact






Drug Patent Expirations for November 19 2012

Tradename Applicant Generic Name Patent
Expiration
PROPECIA Merck finasteride Nov 19, 2012
PROSCAR Merck finasteride Nov 19, 2012

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.








DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details


DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.

Continue reading

Drug Patent Expirations for Nov 21 2012

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations


ADVERTISE
HERE

This
newsletter is a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents


Simple flat-rate database subscription
plans

Ultimate Plan Premium
Plan
Basic Plan
One year $1,995 Subscribe $1,795 Subscribe $1,095 Subscribe
One month $525 Subscribe $425 Subscribe $325 Subscribe
48 hours $95 Subscribe $75 Subscribe
Free
Trial
    Plan
comparison
    Site
tour
    Discount
schedule
    Contact






Drug Patent Expirations for November 21 2012

Tradename Applicant Generic Name Patent
Expiration
CYCLOSET Veroscience bromocriptine mesylate Nov 21, 2012

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.








DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details


DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.

Share this:


Continue reading

Learn From Derek Jeter Weight Fiasco: Consumer Reporter Releases Video…

Derek Jeter's weight gain photo after ankle injury goes viral. Consumer Reporter releases a new video report about a…(PRWeb December 01, 2012)Read the full story at http://www.prweb.com/releases/2012/12/prweb10188731.htm


Continue reading

Life Solutions Advocates Announces Health Promotion and Disease…

Life Solutions Advocates (LSA) is a dynamic and growing association of professionals from many disciplines with a unified purpose to change lives. The…(PRWeb December 01, 2012)Read the full story at http://www.prweb.com/releases/Lifesolutionadvoca…


Continue reading

Burns Engineering Releases Technical Compendium on Averaging and…

Traditional temperature sensors don't always meet the application need, especially when the area of interest is large volume such as a storage room, HVAC duct, tank, or bulk material vessel. This…(PRWeb November 30, 2012)Read the full story a…


Continue reading

Drug Patent Expirations in November 2012

Drug Patent Expirations for November 2012

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
SAMSCA
Otsuka America Pharm
tolvaptan
5,258,510
Nov 2, 2012

ALLEGRA ALLERGY
Sanofi Aventis Us
fexofenadine hydrochloride
6,399,632*PED
Nov 11,…


Continue reading

Winning is a Sight for Sore Eyes

MD Stem Cells shows a critical vision has recently come true for a student who overcame blindness using her own stem cells.(PRWeb November 30, 2012)Read the full story at http://www.prweb.com/releases/2012/11/prweb10187261.htm


Continue reading

Bio-IT World Expo Announces 2013 Keynote Speakers

International Experts in Computational Drug Design, Genome Interpretation, and an All-Star CIO Panel Headline 2013 Bio-IT Conference in Boston(PRWeb November 30, 2012)Read the full story at http://www.prweb.com/releases/2012/11/prweb10181703.htm


Continue reading

The Steadman Philippon Research Institute in Vail, Co Unveils New…

Previously named the Department of Clinical Research, the Center for Outcomes-Based Orthopaedic Research continues its mission of improving patient care and outcomes following orthopaedic procedures…(PRWeb November 29, 2012)Read the full story at …


Continue reading

Clinovo Presents at Bio2Device Group on December 4th, 2012

Olivier Roth Invited to Argue Why Life Science Professionals Need to Expand their Skillset. Olivier is Launching the TechTrainings by Clinovo, a Series of Trainings to Learn Clinical SAS Programming.(PRWeb November 30, 2012)Read the full story at ht…


Continue reading